Description

n-(2-(Dimethylamino)-2-Oxoethyl)-2-(4-Ethoxy-n-Methyl-3-(5-Methyl-4-Oxo-7-Propyl-3,4-Dihydroimidazo[5,1-F][1,2,4]Triazin-2-Yl)Phenylsulfonamido)-n-Methylacetamide is a high-purity, complex heterocyclic organic compound designed for advanced research and development. This specialized molecule serves as a critical intermediate or active pharmaceutical ingredient (API) in the synthesis of novel therapeutic agents. It is primarily targeted at pharmaceutical R&D laboratories and fine chemical manufacturers engaged in developing next-generation treatments, particularly in oncology or other specialized therapeutic areas.

Application

• Pharmaceutical Intermediate: A key building block in the synthesis of novel active pharmaceutical ingredients (APIs) for preclinical and clinical research.
• Oncology Research: Used in the development of targeted cancer therapies, leveraging its complex imidazotriazine core structure.
• Biochemical Research: Serves as a tool compound for studying enzyme inhibition, receptor binding, and other biological pathways.
• Fine Chemical Synthesis: Employed in multi-step organic synthesis for creating complex molecules with specific pharmacological properties.
• Contract Manufacturing: Supplied to CDMOs (Contract Development and Manufacturing Organizations) for cGMP production of clinical trial materials.

Basic Information

Item	Details
Product Name	n-(2-(Dimethylamino)-2-Oxoethyl)-2-(4-Ethoxy-n-Methyl-3-(5-Methyl-4-Oxo-7-Propyl-3,4-Dihydroimidazo[5,1-F][1,2,4]Triazin-2-Yl)Phenylsulfonamido)-n-Methylacetamide
CAS No.	906421-01-0
Molecular Formula	C25H34N8O6S
Molecular Weight	574.66 g/mol
Synonyms	906421-01-0; UNII-8JQ5607E6S; 8JQ5607E6S; CHEMBL3186470; BDBM50121257; AKOS009158991; CS-0243885; n-(2-(Dimethylamino)-2-oxoethyl)-2-[(4-ethoxy-3-methyl-2-{[5-methyl-4-oxo-7-propyl-3,4-dihydroimidazo[5,1-f][1,2,4]triazin-2-yl]sulfonyl}phenyl)amino]-n-methylacetamide
EINECS	Contact for details

Quality Control

Our n-(2-(Dimethylamino)-2-Oxoethyl)-2-(4-Ethoxy-n-Methyl-3-(5-Methyl-4-Oxo-7-Propyl-3,4-Dihydroimidazo[5,1-F][1,2,4]Triazin-2-Yl)Phenylsulfonamido)-n-Methylacetamide is manufactured under strict quality management systems. Every batch undergoes rigorous analytical testing, including HPLC, NMR, and MS, to ensure identity, purity, and consistency. We provide comprehensive Certificates of Analysis (COA) with each shipment, detailing all critical quality attributes. Our quality commitment supports compliance with cGMP and ICH guidelines for pharmaceutical intermediates.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (15-25°C). This compound is hygroscopic (moisture-sensitive) and light-sensitive; therefore, containers must be kept sealed under an inert atmosphere (e.g., nitrogen or argon) when not in use to prevent degradation. Keep away from heat and incompatible materials.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (HPLC)	Conforms to reference standard
Identification (IR)	Conforms to structure
Assay (HPLC)	≥ 98.0%
Water Content (KF)	≤ 0.5%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 10 ppm
Related Substances (HPLC)	Total impurities ≤ 2.0% Any single impurity ≤ 0.5%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.